Moreover, HER2 silencing did not alter butein sensitivity in butein-resistant HER2+ luminal HCC-1419 and SKBR-3 cells (Additional file 1: Figure S3), suggesting that HER2 expression does not determine butein sensitivity in HER2+ breast cancer subtype. Here, ERBB2 is linked to breast cancer.